Logo image of CZO.CA

Ceapro Inc (CZO.CA) Stock Fundamental Analysis

TSX-V:CZO - TSX Venture Exchange - CA1499071076 - Common Stock - Currency: CAD

0.225  -0.03 (-11.76%)

Fundamental Rating

2

CZO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 28 industry peers in the Chemicals industry. CZO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CZO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CZO has reported negative net income.
In the past year CZO has reported a negative cash flow from operations.
In multiple years CZO reported negative net income over the last 5 years.
CZO had a positive operating cash flow in 4 of the past 5 years.
CZO.CA Yearly Net Income VS EBIT VS OCF VS FCFCZO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M -6M

1.2 Ratios

CZO has a Return On Assets (-14.98%) which is in line with its industry peers.
CZO has a Return On Equity (-16.91%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -14.98%
ROE -16.91%
ROIC N/A
ROA(3y)2.51%
ROA(5y)1.94%
ROE(3y)2.95%
ROE(5y)2.28%
ROIC(3y)N/A
ROIC(5y)N/A
CZO.CA Yearly ROA, ROE, ROICCZO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

1.3 Margins

CZO has a better Gross Margin (41.07%) than 90.91% of its industry peers.
In the last couple of years the Gross Margin of CZO has declined.
The Profit Margin and Operating Margin are not available for CZO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.6%
GM growth 5Y-4.96%
CZO.CA Yearly Profit, Operating, Gross MarginsCZO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 -60

More info and screens

6

2. Health

2.1 Basic Checks

CZO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CZO remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CZO has more shares outstanding
The debt/assets ratio for CZO is higher compared to a year ago.
CZO.CA Yearly Shares OutstandingCZO.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
CZO.CA Yearly Total Debt VS Total AssetsCZO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

CZO has an Altman-Z score of 3.36. This indicates that CZO is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.36, CZO is doing good in the industry, outperforming 72.73% of the companies in the same industry.
A Debt/Equity ratio of 0.07 indicates that CZO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.07, CZO belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 3.36
ROIC/WACCN/A
WACC7.81%
CZO.CA Yearly LT Debt VS Equity VS FCFCZO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 8.54 indicates that CZO has no problem at all paying its short term obligations.
The Current ratio of CZO (8.54) is better than 93.94% of its industry peers.
A Quick Ratio of 5.49 indicates that CZO has no problem at all paying its short term obligations.
CZO's Quick ratio of 5.49 is amongst the best of the industry. CZO outperforms 87.88% of its industry peers.
Industry RankSector Rank
Current Ratio 8.54
Quick Ratio 5.49
CZO.CA Yearly Current Assets VS Current LiabilitesCZO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

CZO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -206.95%.
CZO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -48.87%.
The Revenue has been decreasing by -3.64% on average over the past years.
EPS 1Y (TTM)-206.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1643.59%
Revenue 1Y (TTM)-48.87%
Revenue growth 3Y-13.95%
Revenue growth 5Y-3.64%
Sales Q2Q%-50.31%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CZO.CA Yearly Revenue VS EstimatesCZO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
CZO.CA Yearly EPS VS EstimatesCZO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 0.01 0.02 0.03 0.04 0.05

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CZO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CZO.CA Price Earnings VS Forward Price EarningsCZO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CZO.CA Per share dataCZO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CZO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Ceapro Inc

TSX-V:CZO (5/31/2024, 7:00:00 PM)

0.225

-0.03 (-11.76%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-23 2024-05-23/amc
Earnings (Next)08-27 2024-08-27/bmo
Inst Owners0.1%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.62M
Analysts84.44
Price Target1.1 (388.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.83
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB 0.63
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.12
BVpS0.36
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.98%
ROE -16.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.07%
FCFM N/A
ROA(3y)2.51%
ROA(5y)1.94%
ROE(3y)2.95%
ROE(5y)2.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.6%
GM growth 5Y-4.96%
F-Score2
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 50.38%
Cap/Sales 10.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.54
Quick Ratio 5.49
Altman-Z 3.36
F-Score2
WACC7.81%
ROIC/WACCN/A
Cap/Depr(3y)35.3%
Cap/Depr(5y)30.76%
Cap/Sales(3y)5.37%
Cap/Sales(5y)4.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-206.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1643.59%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-48.87%
Revenue growth 3Y-13.95%
Revenue growth 5Y-3.64%
Sales Q2Q%-50.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-215.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-173.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-154.59%
OCF growth 3YN/A
OCF growth 5YN/A